ERBB2 and breast cancer: Additionally, we investigated DRAIC expression in Oncomine database and found DRAIC expression also predicts patients’ response to anticancer drugs like paclitaxel and FEC (Fluorouracil, Epirubicin, and Cyclophosphamide, which are commonly used drugs in chemotherapy) and lapatinib (which is a used to treat women with HER2 positive breast cancer).